11.2 Targeted Medication Review (TMR)
Key Takeaways
- A TMR focuses on specific actual or potential medication-related problems—unlike a CMR, which is a comprehensive interactive review of the full regimen.
- In Part D MTM, sponsors must perform TMRs for enrolled beneficiaries at least quarterly, beginning upon enrollment, with follow-up interventions when necessary.
- TMR topics commonly include adherence gaps, duplications, high-risk medications, unresolved prior problems, new drug therapy problems, and transitions of care.
- TMR assessments may involve the beneficiary or be system-generated; sponsors must determine whether beneficiary and/or prescriber follow-up is needed.
- The CMS Standardized Format written summary is required after a CMR, not automatically after every TMR; technicians track quarterly due dates, prep focused charts, and document interventions.
11.2 Targeted Medication Review (TMR)
Quick Answer: A TMR is an ongoing, focused review of a specific actual or potential medication-related problem. In Part D MTM, TMRs occur at least quarterly after enrollment, with follow-up interventions when necessary. Technicians triage alerts, prep focused charts, and track quarterly timelines; pharmacists decide clinical follow-up.
If the CMR is the annual “whole-house inspection,” the TMR is the smoke-alarm response and the scheduled safety walk-through between annual inspections. Domain 3 items often test the quarterly cadence and the focused scope.
What a TMR Is — and Is Not
CMS distinguishes a TMR from a CMR: a TMR is focused on specific actual or potential medication-related problems, while a CMR is a comprehensive, real-time, interactive review that produces the Standardized Format written summary.
A TMR may be used to:
- Assess medication use related to a known issue
- Monitor whether unresolved problems still need attention
- Detect new drug therapy problems
- Reassess after a transition of care (hospital/ED/SNF discharge)
| Feature | TMR | Not a TMR |
|---|---|---|
| Scope | One or a few focused MRPs | Full annual comprehensive consult by default |
| Trigger | Alert, adherence gap, high-risk drug, prior open issue, care transition | Random refill pickup with no clinical focus |
| Output | Focused assessment + intervention/follow-up as needed | Automatically generating the full CMR Standardized Format |
| Cadence | At least quarterly for Part D MTM enrollees | “Whenever we feel like it” with no tracking |
Trap: calling every phone call a TMR, or skipping quarterly TMRs because “the CMR was last month.” Enrollment starts the TMR clock immediately; quarterly reviews continue alongside the annual CMR obligation.
Part D Cadence: At Least Quarterly After Enrollment
For ongoing monitoring, Part D sponsors must perform TMRs for all beneficiaries enrolled in the MTM program at least quarterly, beginning immediately upon enrollment, with follow-up interventions when necessary.
| Timing concept | Operational meaning |
|---|---|
| Upon enrollment | Do not wait until the annual CMR to start targeted monitoring |
| At least quarterly | Minimum four TMR cycles per year while enrolled (program may do more) |
| Follow-up when necessary | Not every TMR requires a long call—but findings must be assessed for needed action |
| Documented count | Plans report TMR activity; desk workflows must capture dates and outcomes |
Technicians maintain due-date queues: which enrollees are due this quarter, which TMRs are pending vs complete, and which findings are waiting on pharmacist or prescriber action.
Common TMR Focus Areas
Adherence
- PDC below goal on diabetes, cholesterol, hypertension, or other chronic therapies
- Early refill requests that suggest misuse vs late fills that suggest gaps
- Patient-reported barriers: cost, side effects, confusion, transportation
Duplications and therapeutic overlap
- Same drug from two pharmacies (brand + generic both active)
- Two drugs in the same class (two ACE inhibitors, two SSRIs, two NSAIDs)
- Overlapping acetaminophen sources (Rx combo + OTC)
High-risk medications
- Anticoagulants with NSAID/OTC bleed risk
- Beers Criteria PIMs in older adults
- Narrow therapeutic index drugs with toxicity cues or missing labs on file
- Opioid + benzodiazepine combinations
Transitions and unresolved issues
- New discharge list conflicting with community profile
- Open MAP items from the last CMR still incomplete
- Prior prescriber recommendation with no response logged
| Focus area | Example TMR question | Technician prep cue |
|---|---|---|
| Adherence | Why did statin fills stop? | Pull fill dates, note last pickup, ask barrier script |
| Duplication | Are both lisinopril and enalapril active? | Show both claim lines side by side |
| High-risk | Is patient still taking ibuprofen with warfarin? | Flag OTC + anticoagulant pair |
| Transition | Does discharge metoprolol match home therapy? | Attach discharge med list to chart |
| Unresolved | Did potassium get rechecked after spironolactone increase? | Surface last lab date on file |
How TMRs Are Performed
CMS notes that TMR assessments could be done with the beneficiary or be system generated. Sponsors must assess findings to decide whether a follow-up intervention is necessary for the beneficiary and/or their prescriber.
| TMR pathway | What happens | Tech role |
|---|---|---|
| System-generated review | Software flags MRP patterns from claims/clinical rules | Triage queue; attach supporting claims; escalate |
| Beneficiary contact | Focused call/visit about the specific issue | Schedule outreach; document contact attempts |
| Prescriber follow-up | Recommendation or clarification sent when needed | Route faxes/portals; track pending responses |
| No further action | Assessment finds issue resolved or not actionable now | Close with clear rationale fields per site policy |
Role boundary: a system flag is a screen, not an automatic clinical conclusion. Technicians organize evidence; pharmacists determine whether therapy should change.
CMR vs TMR Comparison Table (Exam Core)
| Dimension | CMR | TMR |
|---|---|---|
| Primary aim | Comprehensive interactive review of overall medication use | Focused review of specific actual/potential MRPs |
| Part D minimum frequency | Offer at least every 365 days | Perform at least quarterly while enrolled |
| Starts when | Offer window after enrollment; annual thereafter | Immediately upon MTM enrollment |
| Interactive consult | Required (person-to-person or telehealth) | May be person-facing or system-supported assessment |
| CMS Standardized Format | Required written summary (CL + MAP + PML) | Not required merely because a TMR occurred |
| Typical problems | Full MRP list across the regimen | Adherence, duplication, high-risk drug, transition, unresolved item |
| Follow-up | MAP actions + documentation/follow-up element | Follow-up interventions when necessary for patient and/or prescriber |
| Technician emphasis | Annual offer tracking + full prep + summary assembly | Quarterly due dates + alert triage + focused documentation |
Realistic TMR Scenarios
Scenario A — Quarterly adherence TMR
Mr. Nguyen’s statin PDC drops. The technician pulls fill history, confirms the patient stopped after muscle aches, and schedules a focused pharmacist call. The pharmacist performs a targeted review on statin intolerance and documents a prescriber recommendation—without converting the encounter into a full annual CMR unless clinically/programmatically indicated.
Scenario B — Duplication alert
Claims show both brand and generic of the same ARB active. The technician flags both lines, verifies the patient has bottles from two pharmacies, and escalates. The TMR focuses on stopping the duplicate source and updating the medication list.
Scenario C — System TMR with needed follow-up
A rules engine flags new opioid + benzodiazepine overlap. Even without a patient-initiated call, the team assesses the finding and initiates pharmacist outreach/prescriber communication as needed. Quarterly TMR duty is met by performing and documenting the targeted assessment—not by ignoring the alert until next year’s CMR.
Scenario D — Summary document trap
A coworker reprints the entire CMR Standardized Format after every weekly adherence check. Correct teaching: Standardized Format is for CMRs; TMRs need focused documentation and interventions, not automatic full Format packets (unless your site separately chooses extra patient materials).
Scenario E — Enrollment day
A patient enrolls in Part D MTM in March. Waiting until December “because the CMR is scheduled then” fails the immediate quarterly TMR expectation. Start targeted monitoring now.
Technician quarterly TMR checklist
- Enrollment date and quarter-due list reviewed
- Open CMR MAP items and prior unresolved MRPs scanned
- New high-risk or adherence alerts attached to the chart
- Transition-of-care patients prioritized
- Pharmacist assessment / intervention outcome documented
- Pending prescriber responses tracked to closure or next follow-up date
Master this section by being able to say in one breath: TMR = focused MRP review, at least quarterly from enrollment, follow up when needed, Standardized Format not required like a CMR.
In Medicare Part D MTM, when must Targeted Medication Reviews (TMRs) begin and how often must they occur at minimum?
How does a TMR primarily differ from a CMR?
Which issue is a classic TMR focus rather than a full annual CMR by itself?
A system-generated quarterly TMR flags a possible duplicate ACE inhibitor. What is the technician’s best next step?